Evaluation of the VeriStrat<sup>®</sup> serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Gadgeel, S.; Goss, G.; Soria, J.-C.; Felip, E.; Georgoulias,; Lu, S.; Cobo, M.; Syrigos, K.; Lee, K. H.; Göker, E.; Guclu, S. Z.; Isla, D.; Morabito, A.; Dupuis, N.; Bühnemann, C.; Krämer, N.; Solca, F.; Ehrnrooth, E.; Ardizzoni, A.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Evaluation of the VeriStrat<sup>®</sup> serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Journal article published in 2017 by S. Gadgeel, G. Goss, J.-C. Soria, E. Felip, Georgoulias, S. Lu, M. Cobo, K. Syrigos, K. H. Lee, E. Göker, S. Z. Guclu, D. Isla, A. Morabito, N. Dupuis, C. Bühnemann and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload